Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI
Status:
Completed
Trial end date:
2018-07-25
Target enrollment:
Participant gender:
Summary
Healthy male and female volunteers without asthma will be recruited to enroll in a single
dose 3-way crossover study of the safety and pharmacokinetics of albuterol when administered
using the Halix (TM) albuterol unit dose disposable dry powder inhaler (DPI) and the
albuterol HFA (hydrofluoroalkane) MDI inhaler.